Saba Capital Management, L.P. Purchases 15,455 Shares of BlackRock Health Sciences Term Trust (NYSE:BMEZ) Stock

BlackRock Health Sciences Term Trust (NYSE:BMEZ) major shareholder Saba Capital Management, L.P. acquired 15,455 shares of the firm’s stock in a transaction on Thursday, September 19th. The stock was purchased at an average price of 16.14 per share, for a total transaction of 249,443.70. Following the completion of the transaction, the insider now directly owns 20,601,568 shares in the company, valued at approximately 332,509,307.52. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Major shareholders that own 10% or more of a company’s stock are required to disclose their transactions with the SEC.

Saba Capital Management, L.P. also recently made the following trade(s):

• On Tuesday, September 17th, Saba Capital Management, L.P. acquired 27,148 shares of BlackRock Health Sciences Term Trust stock. The stock was purchased at an average price of 15.93 per share, for a total transaction of 432,467.64.

BlackRock Health Sciences Term Trust Stock Down 0.1 %

BMEZ traded down 0.01 during mid-day trading on Monday, reaching 16.00. The stock had a trading volume of 42,471 shares, compared to its average volume of 276,843. BlackRock Health Sciences Term Trust has a 52 week low of 12.93 and a 52 week high of 16.59. The firm’s fifty day simple moving average is 15.85 and its two-hundred day simple moving average is 15.56.

BlackRock Health Sciences Term Trust Announces Dividend

The business also recently declared a monthly dividend, which will be paid on Thursday, October 31st. Stockholders of record on Tuesday, October 15th will be given a $0.176 dividend. The ex-dividend date of this dividend is Tuesday, October 15th. This represents a $2.11 annualized dividend and a dividend yield of 13.20%.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently made changes to their positions in BMEZ. Pine Valley Investments Ltd Liability Co raised its stake in BlackRock Health Sciences Term Trust by 6.7% during the 4th quarter. Pine Valley Investments Ltd Liability Co now owns 13,088 shares of the company’s stock worth $192,000 after buying an additional 822 shares during the period. Dakota Wealth Management raised its stake in shares of BlackRock Health Sciences Term Trust by 5.3% in the 2nd quarter. Dakota Wealth Management now owns 18,242 shares of the company’s stock valued at $280,000 after purchasing an additional 915 shares during the period. Benjamin F. Edwards & Company Inc. raised its stake in shares of BlackRock Health Sciences Term Trust by 21.7% in the 1st quarter. Benjamin F. Edwards & Company Inc. now owns 5,830 shares of the company’s stock valued at $96,000 after purchasing an additional 1,038 shares during the period. Oppenheimer & Co. Inc. raised its holdings in BlackRock Health Sciences Term Trust by 2.0% during the fourth quarter. Oppenheimer & Co. Inc. now owns 76,699 shares of the company’s stock worth $1,124,000 after acquiring an additional 1,536 shares in the last quarter. Finally, Kingswood Wealth Advisors LLC raised its holdings in BlackRock Health Sciences Term Trust by 9.2% during the first quarter. Kingswood Wealth Advisors LLC now owns 21,988 shares of the company’s stock worth $360,000 after acquiring an additional 1,845 shares in the last quarter.

About BlackRock Health Sciences Term Trust

BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.